FDA Seizes Illegal Medicines Worth ₹80,000 From Bhiwandi Eye Hospital

Mumbai: The Maharashtra Food and Drug Administration (FDA) seized illegal stock of medicines worth Rs80,000 from Aarav Eye Hospital in Bhiwandi on February 9 after a tip-off. This is the second such raid this year.

Earlier this month, the FDA busted a counterfeit medicine racket in Nagpur and seized 21,600 tablets of ciprofloxacin procured through a government contract. Samples of this drug were taken in March last year  but its results that it lacked any therapeutic value came in December.

In the present case, the eye hospital, owned by Dr Ashwin Bafna, didn’t have the licence to stock medicines. The hospital was established in 2005 and opened its second branch in Mira Road in 2017. The Bhiwandi branch opened in 2021.

A senior FDA official said that the pharmacist, Mohammad Ansari, didn’t have the licence required under the provisions of Drugs and Cosmetics Act, 1940 and Rules thereunder. Ansari initially told officials that he has the Pharmacists Registration Certificate issued by the Maharashtra Pharmacy Council but could not produce it; he later admitted not having any qualification as a pharmacist, the FDA official said. He added that the medicines seized can be sold only on the advice of a physician.

The official said, “Samples were drawn from the available stock and sale bills issued on and before February 9 were taken into custody.”

Related Posts

  • Pharma
  • October 17, 2024
  • 113 views
CSIR-NIIST To Establish Centres Of Excellence In Ayurveda, Performance Chemicals

Thiruvananthapuram:  The Centre of Excellence in Ayurveda Research to be established on the campus of the CSIR-National Institute for Interdisciplinary Science and Technology (NIIST) at Pappanamcode here is envisaged as…

  • Pharma
  • October 17, 2024
  • 92 views
India, Uzbekistan Discuss Ways To Ensure Quality, Safety In Pharma Sector

New Delhi:  A delegation from Uzbekistan met officials from India’s Central Drugs Standard Control Organisation and discussed areas of collaboration, including the development of a pharmacovigilance system and reducing adverse…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CSIR-NIIST To Establish Centres Of Excellence In Ayurveda, Performance Chemicals

CSIR-NIIST To Establish Centres Of Excellence In Ayurveda, Performance Chemicals

India, Uzbekistan Discuss Ways To Ensure Quality, Safety In Pharma Sector

India, Uzbekistan Discuss Ways To Ensure Quality, Safety In Pharma Sector

Health Worker Arrested For Mixing TB Patient’s Sputum In Doctor’s Food

Health Worker Arrested For Mixing TB Patient’s Sputum In Doctor’s Food

Cipla, Alkem Eye Rs 4,000 Crore Stake In India’s Largest Stent Manufacturer

Cipla, Alkem Eye Rs 4,000 Crore Stake In India’s Largest Stent Manufacturer

DTAB Recommends To Do Away With Toxicity Studies For Intravenous Infusions And Injectables

DTAB Recommends To Do Away With Toxicity Studies For Intravenous Infusions And Injectables

Delhi-Gujarat Haul: Drugs Brought From S America, Purified In Ankleshwar

Delhi-Gujarat Haul: Drugs Brought From S America, Purified In Ankleshwar